Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation

Clinical Therapeutics

Volumn 38, Issue 1, 2016, Pages 16-30

  Moise, Pamela A ^a   Culshaw, Darren L ^a   Wong Beringer, Annie ^b   Bensman, Joyce ^b   Lamp, Kenneth C ^a   Smith, Winter J ^c   Bauer, Karri ^d   Goff, Debra A ^d   Adamson, Robert ^e   Leuthner, Kimberly ^f   Virata, Michael D ^g   McKinnell, James A ^h   Chaudhry, Saira B ⁱ   Eskandarian, Romic ^j   Lodise, Thomas ^k   Reyes, Katherine ^l   Zervos, Marcus J ^l  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e Saint Barnabas Health Care System   (United States)

^f University Medical Center of Southern Nevada   (United States)

^g YALE NEW HAVEN HOSPITAL   (United States)

^h Memorial Medical Center   (United States)

ⁱ JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^j Glendale Adventist Medical Center   (United States)

^k ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^l WAYNE STATE UNIVERSITY   (United States)

more..

Author keywords

high MIC; Key words daptomycin; MRSA bacteremia; multicenter; vancomycin

Indexed keywords

BETA LACTAM ANTIBIOTIC; CONTRAST MEDIUM; CREATINE KINASE; DAPTOMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENTAMICIN; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEPHROTOXICITY; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; BACTEREMIA; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPLICATION; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; RECURRENT DISEASE; REGRESSION ANALYSIS; STAPHYLOCOCCAL INFECTIONS; TUMOR RECURRENCE;

ACUTE KIDNEY INJURY; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPENSITY SCORE; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT FAILURE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84954371143     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2015.09.017     Document Type: Article

References (24)

1. G. Sakoulas, P.A. Moise-Broder, J. Schentag, and et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2004 2398 2402
2. L.K. Hidayat, D.I. Hsu, R. Quist, and et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 2006 2138 2144
3. A. Soriano, F. Marco, J.A. Martinez, and et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 2008 193 200
4. T.P. Lodise, J. Graves, A. Evans, and et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin Antimicrob Agents Chemother 52 2008 3315 3320
5. Moise PA, Culshaw DL, Wong-Beringer A, et al. 2013. Patterns of antibiotic utilization for MRSA bloodstream infections with vancomycin MIC 1.5-2.0 mg/L: a multi-center evaluation, Abstr. 1733. IDWeek 2013, San Francisco, CA.
6. R. Kullar, S.L. Davis, K.S. Kaye, and et al. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia Pharmacotherapy 33 2013 3 10
7. J.A. Crompton, D.S. North, M. Yoon, and et al. Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs J Antimicrob Chemother 65 2010 1784 1791
8. K.P. Murray, J.J. Zhao, S.L. Davis, and et al. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study Clin Infect Dis 56 2013 1562 1569
9. C.L. Moore, P. Oaki-Kiyan, N.Z. Hague, and et al. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study Clin Infect Dis 54 2011 51 58
10. C. Liu, A. Bayer, S.E. Cosgrove Infectious Diseases Society of America Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 e18 e55
11. V.G. Fowler Jr., H.W. Boucher, G.R. Corey, and et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 2006 653 665
12. C. McCalla, D.S. Smyth, D.A. Robinson, and et al. Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia Antimicrob Agents Chemother 52 2008 3441 3443
13. V.G. Fowler Jr., L. Sanders, D. Sexton, and et al. Outcomes of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients Clin Infect Dis 27 1998 478 486
14. T. Lahey, R. Shah, J. Gittzus, and et al. Infectious diseases consultants lowers mortality from Staphylococcus aureus bacteremia Medicine (Baltimore) 88 2009 263 267
15. A. Borer, J. Gilad, N. Meydan, and et al. Impact of regular attendance by infectious disease specialists on the management of hospitalized adults with community-acquired febrile syndromes Clin Microbiol Infect 10 2004 911 916
16. L.J. Eron, and S. Passos Early discharge of infected patients through appropriate antibiotic use Arch. Int. Med 161 2001 61 65
17. J. Gomez, S.J. Conde Cavero, J.L. Hernandez Cardona, and et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital J Antimicrob Chemother 38 1996 309 314
18. M.J. Rybak, B.M. Lomaestro, J.C. Rotschafer, and et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists Clin Infect Dis 49 2009 325 327
19. C. Cervera, X. Castaneda, C. Garcia de la Maria, et al. and The Hospital Clinic Endocarditis Study Group Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis Clin Infect Dis 58 2014 1668 1675
20. N.F. Holmes, J.D. Turnidge, W.J. Munckhof, and et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations J Infect Dis 204 2011 340 347
21. L.I. Mortin, T. Li, A.D. Van Praagh, and et al. Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria Antimicrob Agents Chemother 51 2007 1787 1794
22. A.M. Chaftari, R. Hachem, V. Mulanovich, and et al. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients Int J Antimicrob Agents 36 2010 182 186
23. S.J. vanHal, D.L. Paterson, and T.P. Lodise Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter Antimicrob Agents Chemother 57 2013 733 744
24. R.G. Wunderink, M.S. Niederman, M.H. Kollef, and et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: A randomized, controlled study Clin Infect Dis 54 2012 621 629